Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistanse testing

Article Abstract:

Research has been conducted on HIV reverse transcriptase evolution and protease-associated antiretroviral drug resistance mutations during genotypic drug resistant testing. Results demonstrate that there is association between duration of previous protease-associated antiretroviral therapy and gain of reverse transcriptase-associated resistance mutations, and that the patients should continue current therapy until test results are available.

Author: Cooper, David, Birch, Chris, Hoy, Jennifer, Middleton, Tracey, Hales, Gillian, Law, Matthew, Crowe, Suzanne, Emery, Sean
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2003
Australia, Drug resistance

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

Article Abstract:

Research has been conducted on protease inhibitor atazanavir. The dose levels of this medication have been compared with those of nelfinavir as a monotherapy and in combination with didanosine and stavudine, and the results of this clinical trial carried out to compare safety, tolerability and antiretroviral efficacy of these three doses are reported.

Author: Squires, Kathleen, Sanne, Ian, Piliero, Peter, Thirty, Alexandra, Schnittman, Steven
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2003
United States, South Africa, Usage, Clinical trials, Comparative analysis, Dosage and administration, Stavudine, Didanosine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

Article Abstract:

The author discusses resistance to nonnucleoside reverse transcriptase inhibitor resistance testing. Results demonstrate that resistance testing favourably drives the switch of highly active antiretroviral therapy regiments, especially during virologic failure.

Author: Manfredi, Roberto
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Italy, Genotype, Genotypes, Highly active antiretroviral therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Care and treatment, Research, Methods, Analysis, Prevention, Physiological aspects, Statistics, Gene mutations, Gene mutation, HIV infection, Drug therapy, HIV infections, Genetic aspects, HIV patients, Antiviral agents, AIDS (Disease), Epidemiology, AIDS research, AIDS treatment, Antiretroviral agents
Similar abstracts:
  • Abstracts: Preventing health care-associated infections during enteral feeding. Preventing infection associated with central venous catheters
  • Abstracts: Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols
  • Abstracts: Opportunities for nurses in a private finance initiative. Evaluation of an evidence-based nursing tool for acute hospitals
  • Abstracts: Let's hear it for nurses in care homes. Nursing homes can enhance your skills
  • Abstracts: Government moves to enshrine infection control in law. Nursing wherever they are needed. Slowing the progression?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.